A Day Up For Tocagen Inc.

Fri 21 Feb 20 at 05:30 PM

Tocagen Inc. (TOCA:NASDAQ) rocketted at $1.9, a gain of 111.1%. On Thu 20 Feb 20, TOCA:NASDAQ touched a New 2-Week High of $0.9. The stock appeared on our News Catalysts scanner on Thu 20 Feb 20 at 12:43 PM in the 'BIOTECH' category. From Thu 30 Jan 20, the stock recorded 35.71% Up Days and 33.33% Green Days

About Tocagen Inc. (TOCA:NASDAQ)

Tocagen Inc is a clinical-stage, cancer-selective gene therapy company focused on developing product candidates designed to activate a patient's immune system against cancer from within.

Top 10 Gainers:

Tocagen Inc. (TOCA:NASDAQ), 111.11%
Trans World Entertainment Corporation (TWMC:NASDAQ), 50.86%
Unit Corporation (UNT:NYSE), 37.02%
Celldex Therapeutics, Inc. (CLDX:NASDAQ), 35.24%
Ducommun Incorporated (DCO:NYSE), 33.09%
Eldorado Gold Corporation (EGO:NYSE), 32.05%
Avadel Pharmaceuticals plc (AVDL:NASDAQ), 32.02%
Genprex, Inc. (GNPX:NASDAQ), 21.69%
Kirkland's, Inc. (KIRK:NASDAQ), 20.66%
IGM Biosciences, Inc. (IGMS:NASDAQ), 20.25%